NO983453L - Fremgangsmåte for ökning av sfinkterfunksjon - Google Patents
Fremgangsmåte for ökning av sfinkterfunksjonInfo
- Publication number
- NO983453L NO983453L NO983453A NO983453A NO983453L NO 983453 L NO983453 L NO 983453L NO 983453 A NO983453 A NO 983453A NO 983453 A NO983453 A NO 983453A NO 983453 L NO983453 L NO 983453L
- Authority
- NO
- Norway
- Prior art keywords
- procedures
- human
- compound
- formula
- effective amount
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 210000005070 sphincter Anatomy 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000034347 Faecal incontinence Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 208000029493 gastroesophageal disease Diseases 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- -1 pyrrolidino, hexamethylenimino Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1077196P | 1996-01-29 | 1996-01-29 | |
| GBGB9603147.1A GB9603147D0 (en) | 1996-02-15 | 1996-02-15 | Methods of increasing sphincter competence |
| PCT/US1997/001159 WO1997026876A1 (en) | 1996-01-29 | 1997-01-27 | Methods of increasing sphincter competence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983453D0 NO983453D0 (no) | 1998-07-27 |
| NO983453L true NO983453L (no) | 1998-09-11 |
Family
ID=26308706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983453A NO983453L (no) | 1996-01-29 | 1998-07-27 | Fremgangsmåte for ökning av sfinkterfunksjon |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0910378A4 (cs) |
| JP (1) | JP2000503991A (cs) |
| CN (1) | CN1213303A (cs) |
| AU (1) | AU732473B2 (cs) |
| CZ (1) | CZ235598A3 (cs) |
| EA (1) | EA001103B1 (cs) |
| HU (1) | HUP9903440A3 (cs) |
| IL (1) | IL125522A0 (cs) |
| NO (1) | NO983453L (cs) |
| NZ (1) | NZ331085A (cs) |
| WO (1) | WO1997026876A1 (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| US6455568B2 (en) | 2000-07-06 | 2002-09-24 | Wyeth | Combination therapy for inhibiting sphincter incontinence |
| WO2002003989A2 (en) * | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for treating sphincter incontinence |
| US6376486B1 (en) | 2000-07-06 | 2002-04-23 | American Home Products Corporation | Methods of inhibiting sphincter incontinence |
| US20040248989A1 (en) * | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
| MX2008014825A (es) | 2006-05-22 | 2008-12-01 | Hormos Medical Ltd | Moduladores selectivos del receptor de estrogeno o inhibidores de aromatasa para tratar prostatitis cronica no bacteriana. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5391557A (en) * | 1993-10-15 | 1995-02-21 | Eli Lilly And Company | Methods for the treatment of peri-menopausal syndrome |
| US5492927A (en) * | 1993-12-21 | 1996-02-20 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists to treat allergy |
| US6562862B1 (en) * | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
| AU3899595A (en) * | 1994-12-02 | 1996-06-19 | Mostyn Farmer | Golf stance training aid |
| US5789442A (en) * | 1996-01-18 | 1998-08-04 | Schering Aktiengesellschaft | Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
-
1997
- 1997-01-27 CZ CZ982355A patent/CZ235598A3/cs unknown
- 1997-01-27 CN CN97191918A patent/CN1213303A/zh active Pending
- 1997-01-27 JP JP9527033A patent/JP2000503991A/ja active Pending
- 1997-01-27 IL IL12552297A patent/IL125522A0/xx unknown
- 1997-01-27 NZ NZ331085A patent/NZ331085A/en unknown
- 1997-01-27 EP EP97903959A patent/EP0910378A4/en not_active Withdrawn
- 1997-01-27 AU AU18386/97A patent/AU732473B2/en not_active Ceased
- 1997-01-27 WO PCT/US1997/001159 patent/WO1997026876A1/en not_active Application Discontinuation
- 1997-01-27 EA EA199800676A patent/EA001103B1/ru not_active IP Right Cessation
- 1997-01-27 HU HU9903440A patent/HUP9903440A3/hu unknown
-
1998
- 1998-07-27 NO NO983453A patent/NO983453L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000503991A (ja) | 2000-04-04 |
| CZ235598A3 (cs) | 1999-03-17 |
| AU1838697A (en) | 1997-08-20 |
| HUP9903440A3 (en) | 2000-07-28 |
| EP0910378A4 (en) | 1999-06-23 |
| HUP9903440A2 (hu) | 2000-06-28 |
| EA001103B1 (ru) | 2000-10-30 |
| NZ331085A (en) | 2000-06-23 |
| EA199800676A1 (ru) | 1999-02-25 |
| NO983453D0 (no) | 1998-07-27 |
| CN1213303A (zh) | 1999-04-07 |
| IL125522A0 (en) | 1999-03-12 |
| WO1997026876A1 (en) | 1997-07-31 |
| EP0910378A1 (en) | 1999-04-28 |
| AU732473B2 (en) | 2001-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971520L (no) | Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y | |
| NO944932D0 (no) | Hemming av trombin | |
| IL115014A0 (en) | Methods of inhibiting viral replication | |
| MX9701360A (es) | Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion. | |
| NO943878L (no) | Hemming av uterinfibrose | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| NO970786L (no) | Fremgangsmåte for hemming av benprotesedegradering | |
| NO983453L (no) | Fremgangsmåte for ökning av sfinkterfunksjon | |
| NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
| NO973367L (no) | Fremgangsmåte for å inhibere miljömessige östrogen | |
| NO973609L (no) | Fremgangsmåte for å inhibere effektene av IL-6 | |
| DK0659414T3 (da) | Inhibering af hirutisme og alopeci hos kvinder | |
| NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin | |
| PH31620A (en) | Benzothiophenes for bone healing and fracture repair. | |
| NO970783L (no) | Fremgangsmåte for å hindre endometrialkreft | |
| MX9701333A (es) | Metodos para inhibir el daño neuronal. | |
| NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter | |
| NO970787L (no) | Fremgangsmåte for hemming av primær endometrial hyperplasi | |
| DK0772438T3 (da) | Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling | |
| NO970784L (no) | Fremgangsmåte for opprettholdelse av tenner og oralt ben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |